Biopharmaceutic characteristics of a new extended-release theophylline formulation (Uni-Dur).

Abstract

BACKGROUND There is a close relationship between improvement in airway function and the plasma concentration of theophylline, as well as between rapidly rising plasma theophylline concentrations and increased frequency of undesired effects. Development of pharmaceutical formulations and prescribed dosage intervals for theophylline dosage forms should… (More)

Topics

Cite this paper

@article{Oosterhuis1995BiopharmaceuticCO, title={Biopharmaceutic characteristics of a new extended-release theophylline formulation (Uni-Dur).}, author={Berend Oosterhuis and Melvin D. Brannan and Harry J. M. Groen and P. W. A. M. Peeters and J. Hempenius and Elaine Radwanski and Amin A. Nomeir and Melton B. Affrime and J H Jonkman}, journal={Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology}, year={1995}, volume={75 2}, pages={157-61} }